164
Views
46
CrossRef citations to date
0
Altmetric
Original Research

Antimicrobial peptide-loaded liquid crystalline precursor bioadhesive system for the prevention of dental caries

, , , , , , , & show all
Pages 3081-3091 | Published online: 25 May 2018

References

  • FejerskovOConcepts of dental caries and their consequences for understanding the diseaseCommunity Dent Oral Epidemiol19972515129088687
  • TakahashiNNyvadBThe role of bacteria in the caries process: ecological perspectivesJ Dent Res201190329430320924061
  • HamadaSSladeHDBiology, immunology, and cariogenicity of Streptococcus mutansMicrobiol Rev19804423313846446023
  • FreiresIARosalenPLHow natural product research has contributed to oral care products development? A critical viewPharm Res20163361311131726975359
  • GorrSUAbdolhosseiniMAntimicrobial peptides and periodontal diseaseJ Clin Periodontol201138Suppl 1112614121323710
  • NiyonsabaFUshioHNakanoNAntimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokinesJ Invest Dermatol2007127359460417068477
  • MccormickTSWeinbergAEpithelial cell-derived antimicrobial peptides are multifunctional agents that bridge innate and adaptive immunityPeriodontol 2000201054119520620712640
  • WiesnerJVilcinskasAAntimicrobial peptides – the ancient arm of the human immune systemVirulence20101544046421178486
  • OuharaKKomatsuzawaHYamadaSSusceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, {beta}-defensins and LL37, produced by human epithelial cellsJ Antimicrob Chemother200555688889615886266
  • GordonYJRomanowskiEGMcDermottAMA review of antimicrobial peptides and their therapeutic potential as anti-infective drugsCurr Eye Res200530750551516020284
  • ZhangLFallaTJHost defense peptides for use as potential therapeuticsCurr Opin Investig Drugs2009102164171
  • ReynoldsNLDe CeccoMTaylorKPeptide fragments of a β-defensin derivative with potent bactericidal activityAntimicrob Agents Chemother20105451922192920176896
  • BhardwajVKumarMNVRFundamentals and applications of controlled release drug delivery advancesSiepmannJSiegelRARathboneMJDelivery Science and TechnologyNew YorkSpringer2012493516
  • LestiniBJSagnellaSMXuZSurface modification of liposomes for selective cell targeting in cardiovascular drug deliveryJ Control Release2002781–323524711772464
  • AvachatAMParpaniSSFormulation and development of bicontinuous nanostructured liquid crystalline particles of efavirenzColloids Surf B Biointerfaces2015126879725543986
  • OkawaraMHashimotoFTodoHEffect of liquid crystals with cyclodextrin on the bioavailability of a poorly water-soluble compound, diosgenin, after its oral administration to ratsInt J Pharm20144721–225726124954725
  • BernegossiJCalixtoGMSanchesPRPeptide KSL-W-loaded mucoadhesive liquid crystalline vehicle as an alternative treatment for multispecies oral biofilmMolecules2015211E3726712726
  • CalixtoGMGarciaMHCilliEMChiavacciLAChorilliMDesign and characterization of a novel p1025 peptide-loaded liquid crystalline system for the treatment of dental cariesMolecules2016212E15826828470
  • GuterresSSAlvesMPPohlmannARPolymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applicationDrug Target Insights2007214715721901071
  • MarquesMRCLoebenbergRAlmukainziMSimulated biological fluids with possible application in dissolution testingDissolution Technologies201181528
  • SalmaziRCalixtoGBernegossiJRamosMABauabTMChorilliMA curcumin-loaded liquid crystal precursor mucoadhesive system for the treatment of vaginal candidiasisInt J Nanomedicine2015104815482426257519
  • CalixtoGYoshiiACRocha e SilvaHStringhetti Ferreira CuryBChorilliMPolyacrylic acid polymers hydrogels intended to topical drug delivery: preparation and characterizationPharm Dev Technol201520449049625975700
  • MerrifieldRBSolid phase peptide synthesis. I. The synthesis of a tetrapeptideJ Am Chem Soc1963851421492154
  • KaiserEColescottRLBossingerCDCookPIColor test for detection of free terminal amino groups in the solid phase synthesis of peptidesAnal Biochem19703425955985443684
  • CruscaERezendeAAMarchettoRInfluence of N-terminus modifications on the biological activity, membrane interaction, and secondary structure of the antimicrobial peptide Hylin-a1Biopolymers2011961414820560142
  • HuFQHongYYuanHPreparation and characterization of solid lipid nanoparticles containing peptideInt J Pharm20042731–2293515010127
  • GawandePVLeungKPMadhyasthaSAntibiofilm and antimicrobial efficacy of DispersinB®-KSL-W peptide-based wound gel against chronic wound infection associated bacteriaCurr Microbiol201468563564124445333
  • CLSI – Clinical and Laboratory Standard InstituteMethods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically9th edWayne, PACLSI Document2012M7M9
  • Mattos-GranerRONapimogaMHFukushimaKDuncanMJSmithDJComparative analysis of Gtf isozyme production and diversity in isolates of Streptococcus mutans with different biofilm growth phenotypesJ Clin Microbiol200442104586459215472313
  • BedranTBMayerMPSpolidorioDPGrenierDSynergistic anti-inflammatory activity of the antimicrobial peptides human beta- defensin-3 (hBD-3) and cathelicidin (LL-37) in a three-dimensional co-culture model of gingival epithelial cells and fibroblastsPLoS One201499e10676625187958
  • LawrenceMJReesDGMicroemulsions-based as novel drug delivery systemsAdv Drug Deliv Rev20004518912111104900
  • CalixtoGMFDesenvolvimento e caracterização de sistemas nano-estruturados bioadesivos contendo peptídeo análogo à adesina do Streptococcus mutans [Development and characterization of nano-structured bioadhesives containing peptide analogue to Streptococcus mutans adhesin; dissertation]Araraquara, BrazilSão Paulo State University2013 Portuguese
  • ShahJCSadhaleYChilukuriDMCubic phase gels as drug delivery systemsAdv Drug Deliv Rev2001472–322925011311994
  • PestanaKCMicroemulsões biocompatíveis de anfotericina b para administração oral. Estudo estrutural, liberação in vitro e farmacocinética pré-clínica [tesis]Araraquara, BrazilSao Paulo State University2009
  • SchrammGReologia e Reometria. Fundamentos Teóricos e Práticos [Rheology and Rheometry. Theoretical and Practical Fundamentals]São Paulo, BrazilArtliber2006 Portuguese
  • SavicSLukicMJaksicIReichlSTamburicSMüller-GoymannCAn alkyl polyglucoside-mixed emulsifier as stabilizer of emulsion systems: the influence of colloidal structure on emulsions skin hydration potentialJ Colloid Interface Sci2011358118219121421214
  • PènzesTRheological analysis of the structural properties effecting the percutaneous absorption and stability in pharmaceutical organogelsRheol Acta200443457463
  • SmartJDRileyRGTsibouklisJThe retention of C-labelled poly(acrylic acids) on gastric and oesophageal mucosa: an in vitro studyEur J Pharm Sci20032018990
  • Pinheiro da SilvaFMachadoMCAntimicrobial peptides: clinical relevance and therapeutic implicationsPeptides201236230831422659161
  • da SilvaBRde FreitasVANascimento-NetoLGAntimicrobial peptide control of pathogenic microorganisms of the oral cavity: a review of the literaturePeptides201236231532122664320
  • TanzerJMLivingstonJThompsonAMThe microbiology of primary dental caries in humansJ Dent Educ200165101028103711699974
  • GuptaPGuptaNPawarAPBirajdarSSNattASSinghHPRole of sugar and sugar substitutes in dental caries: a reviewISRN Dent2013201351942124490079
  • NyvadBCrielaardWMiraATakahashiNBeightonDDental caries from a molecular microbiological perspectiveCaries Res20134728910223207320
  • BeckerMRPasterBJLeysEJMolecular analysis of bacterial species associated with childhood cariesJ Clin Microbiol20024031001100911880430
  • KrelingPFAidaKLMassunariLCytotoxicity and the effect of cationic peptide fragments against cariogenic bacteria under planktonic and biofilm conditionsBiofouling2016329995100627538256
  • MaisettaGBatoniGEsinSActivity of human β-defensin 3 alone or combined with other antimicrobial agents against oral bacteriaAntimicrob Agents Chemother200347103349335114506056
  • JolySMazeCMcCrayPBJrGuthmillerJMHuman β-defensin 2 and 3 demonstrate strain-selective activity against oral microorganismsJ Clin Microbiol20044231024102915004048
  • NishimuraEEtoAKatoMOral streptococci exhibit diverse susceptibility to human β-defensin – 2: antimicrobial effects of hBD-2 on oral streptococciCurr Microbiol2004482858715057473
  • PrasannaSGVLakshamananRCharacteristics, uses and side effect of chlorhexidine: a reviewJ Dent Med Sci20161565759
  • DaileyLAWittmarMKisselTThe role of branched polyesters and their modifications in the development of modern drug delivery vehiclesJ Control Release20051011–313714915588900
  • ChenYMaPGuiSCubic and hexagonal liquid crystals as drug delivery systemsBiomed Res Int2014201481598124995330
  • PatilSSMahadikKRParadkarARLiquid crystalline phase as a probe for crystal engineering of lactose: carrier for pulmonary drug deliveryEur J Pharm Sci201568435025460546
  • HorevBKleinMIHwangGpH-activated nanoparticles for controlled topical delivery of farnesol to disrupt oral biofilm virulenceACS Nano2015932390240425661192
  • SouzaCWatanabeEBorgheti-CardosoLNde Abreu FantiniMCLaraMGMucoadhesive system formed by liquid crystals for buccal administration of poly(hexamethylene biguanide) hydrochlorideJ Pharm Sci2014103123914392325336429
  • OliveiraMBCalixtoGGraminhaMCerecettoHGonzálezMChorilliMDevelopment, characterization, and in vitro biological performance of fluconazole-loaded microemulsions for the topical treatment of cutaneous leishmaniasisBiomed Res Int2015201539689425650054